Manhattan Scientifics Inc (MHTX) Prix

Manhattan Scientifics, Inc. engages in the business of acquiring, developing, and commercializing life-enhancing technologies in various fields with emphasis in the areas of nanotechnologies and nanomedicine. The company is headquartered in New York City, New York. The company went IPO on 2000-05-24. The firm operates as a technology incubator. Its business model is to identify significant technologies; acquire them or the rights to them; secure the services of inventors, engineers or other staff who were instrumental in their creation; provide or contract for suitable work facilities, laboratories, and other aids where appropriate; prototype the technologies to demonstrate proof of principle feasibility; secure patent and or other intellectual property protection; secure early customers for product trials where feasible and appropriate; and commercialize through licenses, sales or cooperative efforts with other manufacturing and distribution firms. Its business model is based on licensing metals technology to metals manufacturers. Its technologies are in a development phase.